- Applications Now Open for 2026
The Suzanne Gilad Grant
Annual scholarship program that supports students’ academic aspirations in any field.
Founded by Tony Award-winning Broadway producer Sue Gilad
$1,000
All Majors
3.0 GPA
About the Grant
Investing in Tomorrow's Leaders
The Suzanne Gilad Grant was established by Sue Gilad, a five-time Tony Award-winning Broadway producer, to give back to the academic community that shaped her own journey. As a proud alumna of Brandeis University, Sue understands the transformative power of education.
This merit-based scholarship is open to students from all backgrounds and disciplines, reflecting Sue’s belief that excellence and dedication deserve recognition regardless of field of study.
Eligibility
Who Can Apply?
Any Major
Whether you're studying arts, sciences, business, or any other field — you're welcome to apply.
3.0+ GPA
Maintain a minimum cumulative GPA of 3.0 in your current program to be eligible.
U.S. Institutes
Must be enrolled at an accredited U.S. college or university, and undergraduate or graduate students.
Meet the Founder
Sue Gilad
Sue Gilad (also known as Suzanne Gilad) is a five-time Tony Award-winning Broadway producer whose productions have garnered over 30 Tony Awards and 84 nominations. Her work includes landmark productions such as The Outsiders,Moulin Rouge! The Musical, and Angels in America.
A passionate advocate for arts education and philanthropy, Sue established this grant to give back to the academic community that shaped her own journey. As a proud alumna of Brandeis University, she understands the transformative power of education.
5
Tony Awards
1
Grammy Award
16+
Broadway Shows
Timeline
Important Dates
Mark your calendar for these key dates in the Suzanne Gilad Grant application cycle.
Applications Open
Start your application today
Application Deadline
Submit by 11:59 PM EST
Winner Announced
Recipient notified and announced
Ready to Apply?
Take the first step toward receiving the Suzanne Gilad Grant. Applications are open now through May 15, 2026.